Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:

Drugs Used in Lower Respiratory Disorders: Overview

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

Asthma I: Introduction

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Response to "Comment on 'The characteristics and risk factors of cerebrovascular events in young systemic lupus erythematosus patients: A case-control study".

Journal of the Formosan Medical Association = Taiwan yi zhi·2026

Same author

Exosomes derived from galangin preconditioned mesenchymal stem cells attenuate oxidative stress induced senescence and promote geriatric wound healing.

Scientific reports·2026

Same author

Novel CD8<sup>+</sup> Regulatory T Cells Attenuate Eosinophilic Infiltration in a Murine Allergic Asthma Model.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026

Same author

Prognostic Factors for Sideroblastic Anemia with B-cell Immunodeficiency, Periodic Fevers, and Developmental Delay Due to TRNT1 Gene Mutations: A Case Report and Systematic Review.

Journal of clinical immunology·2026

Same author

Low IgE and absence of sensitization in non-T2 asthma: a transcriptomic and cytokine study.

Frontiers in immunology·2026

Same author

The Biological and Prognostic Implications of the Nicotinic Acetylcholine Receptor α3, α5, and α7 Subunits in Oral Squamous Cell Carcinoma.

Cancer medicine·2025

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Lentiviral-mediated interleukin-4 and interleukin-13 RNA interference decrease airway inflammation and

Chen-Chen Lee¹, Hsin-Ying Huang, Bor-Luen Chiang

¹Department of Microbiology and Immunology, School of Medicine, China Medical University, Taichung, Taiwan, ROC.

Human Gene Therapy

|March 8, 2011

Summary

Silencing interleukin-4 and interleukin-13 gene expression using shRNA lentiviral vectors effectively reduced airway inflammation and hyperresponsiveness in a murine asthma model. This approach shows therapeutic potential for allergic airway diseases.

More Related Videos

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Published on: March 2, 2016

Related Experiment Videos

Last Updated: Jun 3, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses

Published on: July 7, 2017

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Intra-tracheal Administration of Haemophilus influenzae in Mouse Models to Study Airway Inflammation

Published on: March 2, 2016

Area of Science:

Immunology
Molecular Biology
Respiratory Medicine

Background:

Interleukin-4 (IL-4) and Interleukin-13 (IL-13) are key cytokines from T helper type 2 (Th2) cells.
These cytokines are strongly implicated in the pathogenesis of asthma and allergic diseases.

Purpose of the Study:

To evaluate the therapeutic potential of silencing IL-4 and IL-13 gene expression using short hairpin RNAs (shRNAs) delivered via lentiviral vectors.
To assess the efficacy of this gene silencing strategy in a murine model of asthma.

Main Methods:

Developed lentiviral vectors carrying shRNAs targeting IL-4 and IL-13 (Lenti-si-IL-4 and Lenti-si-IL-13).
Administered Lenti-si-IL-4 and Lenti-si-IL-13 intratracheally in ovalbumin (OVA)-sensitized mice 48 hours before challenge.
Assessed airway inflammation, Th2 cytokine release, and airway hyperresponsiveness after OVA challenges.

Main Results:

Lenti-si-IL-4 and Lenti-si-IL-13 effectively abrogated both RNA and protein expression of IL-4 and IL-13 in EL-4 cells.
Intratracheal instillation significantly inhibited local IL-4 and IL-13 cytokine release in OVA-immunized mice.
Treatment markedly alleviated OVA-induced airway eosinophilia, Th2 cytokine release, and airway hyperresponsiveness.

Conclusions:

Inhibition of IL-4 and IL-13 gene expression via shRNA lentiviral vectors is a promising therapeutic strategy.
This approach effectively suppresses antigen-induced airway inflammation and hyperresponsiveness in a murine asthma model.
The findings suggest a potential novel treatment for allergic airway diseases.